Published in Toxicol In Vitro on January 28, 2017
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem (1998) 28.13
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem (2009) 23.19
A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res (1988) 17.88
The DNA-damage response in human biology and disease. Nature (2009) 17.86
Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol (1990) 11.00
H2AX: the histone guardian of the genome. DNA Repair (Amst) (2004) 6.65
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (2000) 6.24
Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res (2002) 4.05
Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev (2006) 2.59
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev (2008) 1.91
Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol (1978) 1.79
Occupational exposures to metals as risk factors for Parkinson's disease. Neurology (1997) 1.78
Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC. J Biol Chem (2006) 1.65
Copper and iron disorders of the brain. Annu Rev Neurosci (2007) 1.62
The wanderings of a free radical. Free Radic Biol Med (2008) 1.60
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A (2004) 1.59
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Photoinduction of strand scission in DNA by uric acid and Cu(II) Free Radic Biol Med (1995) 1.40
Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol Scand Suppl (1989) 1.37
Long-lived reactive species on free-radical-damaged proteins. Biochem J (1992) 1.32
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology (2006) 1.31
The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther (1975) 1.28
Role of copper in human neurological disorders. Am J Clin Nutr (2008) 1.23
Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease. FEBS Lett (1994) 1.23
Oxidative stress and its significant roles in neurodegenerative diseases and cancer. Int J Mol Sci (2014) 1.22
Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin Cancer Biol (2007) 1.21
USP3 counteracts RNF168 via deubiquitinating H2A and γH2AX at lysine 13 and 15. Cell Cycle (2013) 1.07
Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J Clin Invest (1995) 1.02
Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama (2008) 1.02
Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors. J Neurooncol (1993) 1.02
DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis (1994) 1.01
Effects of L-dopa on norepinephrine metabolism in the brain. Proc Natl Acad Sci U S A (1971) 0.95
DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays. Carcinogenesis (1995) 0.95
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. Pharmacol Ther (2014) 0.94
Effects of copper on mammalian cell components. Chem Biol Interact (1989) 0.92
Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res (1996) 0.91
Assessment of genotoxic effects by lindane. Food Chem Toxicol (1993) 0.88
An enriched environment increases noradrenaline concentration in the mouse brain. Brain Res (2002) 0.87
Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free Radic Biol Med (2001) 0.87
Oral administration of copper to rats leads to increased lymphocyte cellular DNA degradation by dietary polyphenols: implications for a cancer preventive mechanism. Biometals (2011) 0.87
Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patients. J Neurol Sci (1980) 0.87
Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species. Free Radic Biol Med (2010) 0.86
Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants. Brain Res (1995) 0.86
Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. BMC Cancer (2014) 0.85
Structure Effect on Antioxidant Activity of Catecholamines toward Singlet Oxygen and Other Reactive Oxygen Species in vitro. J Clin Biochem Nutr (2010) 0.85
Oxidation chemistry of norepinephrine: partitioning of the O-quinone between competing cyclization and chain breakdown pathways and their roles in melanin formation. Chem Res Toxicol (2007) 0.85
Bilirubin-Cu(II) complex degrades DNA. Biochim Biophys Acta (1999) 0.83
The status of zinc, copper, and metallothionein in cancer patients. Prog Clin Biol Res (1988) 0.83
Dopa and dopamine cause cultured neuronal death in the presence of iron. J Neurol Sci (1991) 0.82
Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. Mov Disord (1993) 0.81
Prevention of iron- and copper-mediated DNA damage by catecholamine and amino acid neurotransmitters, L-DOPA, and curcumin: metal binding as a general antioxidant mechanism. Dalton Trans (2012) 0.81
Formation of DNA adducts and oxidative base damage by copper mediated oxidation of dopamine and 6-hydroxydopamine. Exp Neurol (1997) 0.80
Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics. Alcohol Clin Exp Res (2005) 0.80
Dopamine induces cell death, lipid peroxidation and DNA base damage in a catecholaminergic cell line derived from the central nervous system. Neurotox Res (2000) 0.80
Meeting report--copper research at the top. Biometals (2000) 0.79
Strand scission in DNA by quercetin and Cu(II): identification of free radical intermediates and biological consequences of scission. Carcinogenesis (1990) 0.79
DNA breakage by tannic acid and Cu(II): generation of active oxygen species and biological activity of the reaction. Mutat Res (1994) 0.78
Strand scission in DNA induced by L-DOPA in the presence of Cu(II). FEBS Lett (1995) 0.78
Enhancement of cytotoxicity and clastogenicity of l-DOPA and dopamine by manganese and copper. Mutat Res (1998) 0.78
Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages. Eur Neurol (1994) 0.77
DNA breakage by L-DOPA and Cu(II): breakage by melanin and bacteriophage inactivation. Mutat Res (1998) 0.76
Pro-oxidant DNA breakage induced by the interaction of L-DOPA with Cu(II): a putative mechanism of neurotoxicity. Adv Exp Med Biol (2015) 0.76